Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

UK Breast Cancer Deaths Plummet

By Drug Discovery Trends Editor | August 12, 2010

LONDON (AP) – The rate at which women died from breast cancer dropped faster in Britain than in any other major European country during the last two decades, according to new research.

In previous studies, Britain has often ranked last among Western Europe for cancer survival rates. The U.K. does not spend as much money on new cancer drugs or other treatments as other countries including France and Germany.

In a study published online in the medical journal BMJ, European researchers analyzed data from the World Health Organization, looking for changes in the breast cancer death rates in 30 European countries from 1980 to 2006.

Among countries including France, Finland and Sweden, the death rate from breast cancer dropped by 10 to 16 percent. In the U.K., it fell by more than 30 percent. The authors said the decreasing death rates could be due to wider breast cancer screening and more targeted treatments.

In an accompanying commentary, Valerie Beral and Richard Peto of the University of Oxford wrote that incomplete records may have led to previously “misleading claims about the supposed inferiority of U.K. cancer treatment.”

Because cancer registration isn’t mandatory in the U.K., many cancer patients may only be picked up shortly before they die, giving the impression they only survive for a short time. Beral and Peto said the rapid drops in Britain’s cancer death rates appear valid.

Date: August 11, 2010
Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE